Literature DB >> 9155048

The Rhesus D-negative phenotype is an independent predictor of poor prognosis in curatively (RO) resected gastric cancer patients.

B Mayer1, W Schraut, I Funke, K W Jauch, W Mempel, J P Johnson, F W Schildberg.   

Abstract

Among gastric cancer patients, the Rhesus D-negative phenotype correlated with increased tumour recurrence [all patients, n = 83, P = 0.026; curatively (R0) resected patients, n = 51, P = 0.093] and reduced overall survival time (all patients, log-rank P = 0.0028; R0 patients, log-rank P = 0.0003) and was identified in multivariate analysis as the most important independent prognostic marker in the R0 patient group (relative risk 9.1, P = 0.0013).

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9155048      PMCID： PMC2228249          DOI： 10.1038/bjc.1997.219

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  16 in total

1.  Prognostic variables in patients with prostate cancer: influence of blood group ABO (H), the Rhesus system, age, differentiation, tumour stage and metastases.

Authors:  E Kvist; J Krogh; P Hjortberg
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

2.  Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas.

Authors:  T Sano; T Tsujino; K Yoshida; H Nakayama; K Haruma; H Ito; Y Nakamura; G Kajiyama; E Tahara
Journal:  Cancer Res       Date:  1991-06-01       Impact factor: 12.701

3.  Prognostic significance of bone marrow micrometastases in patients with gastric cancer.

Authors:  K W Jauch; M M Heiss; U Gruetzner; I Funke; K Pantel; R Babic; H J Eissner; G Riethmueller; F W Schildberg
Journal:  J Clin Oncol       Date:  1996-06       Impact factor: 44.544

4.  Localization of the human Rh blood group gene structure to chromosome region 1p34.3-1p36.1 by in situ hybridization.

Authors:  B Chérif-Zahar; M G Mattéi; C Le Van Kim; P Bailly; J P Cartron; Y Colin
Journal:  Hum Genet       Date:  1991-02       Impact factor: 4.132

5.  Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients.

Authors:  T Cerny; V Blair; H Anderson; V Bramwell; N Thatcher
Journal:  Int J Cancer       Date:  1987-02-15       Impact factor: 7.396

6.  Prevalence of the Rhesus-negative phenotype in Caucasian patients with small-cell lung cancer (SCLC).

Authors:  T Cerny; M F Fey; R Oppliger; M Castiglione; B Nachbur; M Gertsch; A Gasser; R A Joss; N Thatcher; M Lind
Journal:  Int J Cancer       Date:  1992-09-30       Impact factor: 7.396

7.  Clinicopathologic correlations of ABO and Rhesus blood type in colorectal cancer.

Authors:  G Slater; S Itzkowitz; S Azar; A H Aufses
Journal:  Dis Colon Rectum       Date:  1993-01       Impact factor: 4.585

8.  A multivariate study of the prognosis of oral squamous cell carcinomas. Are blood group and hemoglobin new prognostic factors?

Authors:  M Bryne; G E Eide; R Lilleng; F Langmark; P S Thrane; E Dabelsteen
Journal:  Cancer       Date:  1991-11-01       Impact factor: 6.860

9.  Prognostic value of Rhesus blood groups in oral squamous cell carcinomas.

Authors:  M Bryne; P S Thrane; R Lilleng; E Dabelsteen
Journal:  Cancer       Date:  1991-11-15       Impact factor: 6.860

10.  Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992.

Authors:  J D Roder; K Böttcher; J R Siewert; R Busch; P Hermanek; H J Meyer
Journal:  Cancer       Date:  1993-10-01       Impact factor: 6.860
View more
  1 in total

1.  ABO and Rhesus blood groups and risk of endometriosis in a French Caucasian population of 633 patients living in the same geographic area.

Authors:  Bruno Borghese; Mélanie Chartier; Carlos Souza; Pietro Santulli; Marie-Christine Lafay-Pillet; Dominique de Ziegler; Charles Chapron
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.